Union Bancaire Privee’s Aurinia Pharmaceuticals AUPH Stock Holding History

Union Bancaire Privee’s Portfolio AUPH Stock Details AUPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$176K	Hold	13,000	–	–	﹤0.01%	391
2026 Q1	$145K	Hold	13,000	–	–	﹤0.01%	406
2025 Q4	$163K	Hold	13,000	–	–	﹤0.01%	402
2025 Q3	$136K	Buy	+13,000	New	+$142K	﹤0.01%	392
2025 Q2	–	Sell	-13,000	Closed	-$94.9K	–	501
2025 Q1	$94.9K	Hold	13,000	–	–	﹤0.01%	417
2024 Q4	$108K	Buy	+13,000	New	+$106K	﹤0.01%	445

Other funds holding AUPH

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

CAMG

CWA Asset Management Group Naples, Florida $3.28B AUM 34.07% 1-Year Est. Return

YIH

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

CPC

Cookson Peirce & Co Pittsburgh, Pennsylvania $3.04B AUM 94.11% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

STRS Ohio Columbus, Ohio $26.7B AUM 43.32% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Caprock Group Boise, Idaho $5.22B AUM 42.47% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

FHA

Flagship Harbor Advisors Boston, Massachusetts $2.61B AUM 23.21% 1-Year Est. Return

Union Bancaire Privee's AUPH Position: Q2 2026 in Review

Union Bancaire Privee held its Aurinia Pharmaceuticals (AUPH) position steady in Q2 2026 at 13,000 shares worth $176K. The position accounts for ﹤0.01% of the portfolio, ranked #391.

Union Bancaire Privee first reported a position in AUPH in Q4 2024 and has held it in 6 quarters since. 64 funds tracked by Wall St. Rank hold AUPH as of Q2 2026.

Union Bancaire Privee held 13,000 shares of Aurinia Pharmaceuticals worth $176K as of Q2 2026.
Union Bancaire Privee left its Aurinia Pharmaceuticals share count unchanged in Q2 2026.
Aurinia Pharmaceuticals made up ﹤0.01% of Union Bancaire Privee's portfolio in Q2 2026, its #391 holding.
Union Bancaire Privee first reported a position in Aurinia Pharmaceuticals in Q4 2024 and has held it in 6 quarters since.
64 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q2 2026.

Based on Union Bancaire Privee's 13F filing for Q2 2026, filed 16 Jul 2026.